Navigation Links
Tamaulipas Comparative Wound Healing Test Treatment Successfully Concluded

WITTEN, Germany, October 29 /PRNewswire-FirstCall/ -- The comparative study of chronic wound treatment at the Hospital Civil of Cd. Victoria, Tamaulipas, Mexico, was concluded successfully. Due to the significantly superior therapeutic success the Ministry of Health ordered the control to be abandoned and moved to Hemospray treatment for ethical reasons. 22 of the 24 patients within the Hemospray group were healed completely, while 22 of the 24 patients of the control group showed no comparable progress. Moreover, additional patients suffering from diabetic foot disease were successfully treated with Hemospray. The total healing ratio is significantly higher than 75%.

These results were presented to health system representatives of several Latin American countries in Mexico City by the Chief Investigator of the study.

The results are currently being evaluated by the State Health Authorities of Tamaulipas who sponsored the study.

Apart from this, a considerable share of the patient data were crosschecked and evaluated by Sangui in Witten. It turned out that these data confirm the results as previously indicated. Sangui regards this outcome as a confirmation of the outstanding efforts made by the teams on location and as a great success of its systematic competence in wound healing.

SanguiBioTech GmbH is a ninety percent subsidiary of Sangui BioTech International, Inc. ( SGBI)

Some of the statements contained in this news release discuss future expectations, contain projections of results of operation or financial condition or state other "forward-looking" information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions. Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," and variations of such words and similar expressions are intended to identify such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    For more information please contact:

    Joachim Fleing
    Phone: +49(160)741-27-17
    Fax: +49(2302)915-191

SOURCE Sangui Bio Tech International Inc.

SOURCE Sangui Bio Tech International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
2. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
3. Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmers Trabecular Metal(TM) Technology
4. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
5. Wound Management Technologies (OTCBB- WNDM) Signs Biotech Agreement With Biocure S.r.l. of Milan, Italy
6. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
7. Wound Management to Participate at Save A Leg, Save a Life Foundation National Conference
8. Wound Management Technologies Acquires Resorbable Orthopedics
9. Cardium Reports Non-Healing Wounds Continue to Challenge Patients and Healthcare Providers
10. New Data Supports ConvaTec Negative Pressure Wound Therapy
11. New Powder Speeds Healing of Difficult Foot Wounds
Post Your Comments:
(Date:11/27/2015)... YORK , November 27, 2015 ... system is set to go online. The potential to ... processes is vast and far from fully exploited as ... to patient health records, either via mobile tablet or ... ) --> ) --> ...
(Date:11/27/2015)... ) ... "2016 Global Tumor Marker Testing Market: Supplier ... Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive ... offering. --> ) has ... Global Tumor Marker Testing Market: Supplier Shares ...
(Date:11/26/2015)... Netherlands , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... Netherlands has found that immunotherapy can be ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... , ... Dr. Thomas Dunlap and Dr. Patrick Coleman , ... Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , co-hosted ... similar ways and require time-critical intervention to avoid large area heart damage and progressive ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
Breaking Medicine News(10 mins):